Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events (including everything from Summerfest to the Milwaukee Film Festival), access ...
Brazil's Health Regulatory Agency (Anvisa) approved on Monday the use of the drug Sunlenca (lenacapavir) for HIV-1 prevention ...
The Kenya Times on MSN
Kenya to introduce long-acting HIV prevention drug in landmark move
Kenya has taken a major step towards expanding HIV prevention options after the Ministry of Health formally recommended the ...
PLANO, Texas, Jan. 22, 2026 /PRNewswire/ -- Q Care Plus, a telehealth provider known for its leadership in providing HIV ...
Although adolescents and young adults comprise only one quarter of the sexually active population in the United States, ...
HIV medication Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) will be offered free by the end of January, Prime Minister Robert Abela said on Sunday. NGOs and people living ...
Kenya will this year begin rolling out a new long-acting injectable HIV prevention drug, Lenacapavir, positioning the country ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
The “enormous revelation” that drugs can be used to prevent catching HIV has benefitted millions and helped slash ...
SELF-ACCEPTANCE IS A complicated, ongoing journey that can be as demanding as it is gratifying. It involves many ...
The New Times on MSN
Six-month HIV prevention injection set for rollout by year-end
The government plans to introduce lenacapavir, a long-acting injectable drug for HIV prevention, in the last quarter of the year, according to Rwanda Biomedical Centre (RBC). The injection, given once ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results